Bradley Miller
Director Financiero/CFO en Yale Pharmaceuticals, Inc. .
Fortuna: 762 774 $ al 30/04/2024
Perfil
Bradley J.
Miller is currently working as the Chief Financial Officer & Executive Vice President at Yale Pharmaceuticals, Inc.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 25/03/2024 | 244 479 ( 0.32% ) | 762 774 $ | 30/04/2024 |
Cargos activos de Bradley Miller
| Empresas | Cargo | Inicio |
|---|---|---|
Yale Pharmaceuticals, Inc.
 Yale Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Yale Pharmaceuticals, Inc. is a minority-owned business which provides pharmaceutical and health care products. The firm's product categories include gastrointestinal, diagnostics, baby care, cardiology, dental diabetes care, oncology, and orthopedics. It offers pharmaceutical related research, including drug screening, target identification and validation, clinical trial studies, and consulting services. The company was founded in 2005 and is located in Frederick, MD. | Director Financiero/CFO | 22/05/2009 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Yale Pharmaceuticals, Inc.
Yale Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Yale Pharmaceuticals, Inc. is a minority-owned business which provides pharmaceutical and health care products. The firm's product categories include gastrointestinal, diagnostics, baby care, cardiology, dental diabetes care, oncology, and orthopedics. It offers pharmaceutical related research, including drug screening, target identification and validation, clinical trial studies, and consulting services. The company was founded in 2005 and is located in Frederick, MD. | Health Technology |
- Bolsa de valores
- Insiders
- Bradley Miller
